PAR 2.56% 20.0¢ paradigm biopharmaceuticals limited..

PAR has to be one of the most frustrating stocks i have ever...

  1. 360 Posts.
    lightbulb Created with Sketch. 42
    PAR has to be one of the most frustrating stocks i have ever held....honestly the SP performance for 2021 has been woeful. Ive held here for almost 2 years and seen better times but boy the way this has traded after the FDA clearance, you'd think PAR has come back with a positive covid test or something, no one wants to get near it!

    Ever since the debacle of how they handled longer timelines back in december last year, the confidence in PAR has been kicked around all over the place. I wasnt overly concerned with the FDA delays because thats natural progression in biotech space but i honestly hope they will spend a bit of money now properly marketing what they are doing in 2022 and get some confidence back into this stock.....Phase 3 clinical trial and a market cap of 500mill just doesnt make sense to me at all. The shorters are having a field day and the bot keep feeding them
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.